You are here

AusPAR: Voretigene neparvovec

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

16 December 2020
AusPAR Details
AusPAR
Active Ingredient
Voretigene neparvovec
Product Name
Luxturna
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2019-02585-1-5
Submission Type
New biological entity
Decision
Approved
AusPAR Date
15 December 2020
Publication Date

16 December 2020